Biofeedback Global

Dr. Yoko Nagai began her research in electrodermal biofeedback therapy for epilepsy in 1997. This research has since attracted scientific research funding of over £300,000 that has enabled clinical trials and a deeper understanding of the brain mechanisms by which the therapy can reduce the occurrence of epileptic seizures.

Dr. Nagai also founded Biofeedback Global in 2005, in response to demand from patients at the National Hospital for Neurology and Neurosurgery, University College London. Dr Nagai is currently a research fellow at Brighton and Sussex Medical School.